Pipeline

The Future of PrTMS®

PeakLogic is currently working with Walter Reed National Military Medical Center and the Henry M. Jackson Foundation for the Advancement of Military Medicine on an active clinical trial to assess the efficacy of PrTMS® therapy in reducing pain for military health system beneficiaries with chronic neck pain and to describe participants’ perceptions of PrTMS® treatment and its perceived effect on their pain and quality of life.

https://clinicaltrials.gov/study/NCT06214949

PeakLogic is currently working with Massachusetts General Hospital, Home Base and the Air Force Research Laboratory in collaboration with United States Special Operations Command (USSOCOM) to assess the efficacy of PrTMS® therapy as a treatment for post-traumatic stress disorder (PTSD) in military service members and veterans.

https://clinicaltrials.gov/study/NCT07526285

PeakLogic, Inc. plans to continue pursuing clinical research studies evaluating use of our PrTMS® protocol for the treatment of major mental health and neurocognitive disorders, as well as human performance. PeakLogic also hopes to pursue FDA-clearance of new products that may improve TMS therapy more broadly.

PeakLogic® plans to research the potential safety and efficacy of PrTMS® for a variety of conditions, including: